Dry Eye Syndrome Treatment Market: By  Product Type, By Dosage Form, By Prescription, By Distribution Channel, and Geography  

Dry Eye Syndrome Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By  Product Type (Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs, Oral Omega Supplements, Others), By Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments), By Prescription (Rx, OTC, Medical Device), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Eye Health Clinics, Others), and Region  

Dry Eye Syndrome Treatment Market Size was valued at US$ 6,389.2 million in 2023 and is poised to grow at a CAGR of 9.5% during the forecast period 2024-2030. Dry Eye Syndrome (DES) is a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film. The global dry eye syndrome treatment market is experiencing robust growth driven by an aging population, increasing screen time, environmental factors, and growing awareness about eye health. The market is primarily fueled by the rising prevalence of dry eye syndrome, estimated to affect 5-50% of the global population, depending on the definition used and the population studied. The growing adoption of digital devices, leading to increased screen time and reduced blink rates, is contributing significantly to the rise in dry eye syndrome cases.

Additionally, the surge in LASIK and cataract surgeries, which often result in temporary or chronic dry eye, is boosting the demand for treatments. Recent developments in drug delivery systems, including nanotechnology-based formulations and sustained-release devices, have reshaped the treatment landscape. The market is witnessing a shift towards more targeted therapies addressing the underlying causes of dry eye syndrome, rather than just symptom management. However, the dry eye syndrome treatment market faces challenges such as the high cost of advanced treatments, potential side effects of long-term medication use, and the need for more accurate diagnostic tools. Despite these challenges, the market is expected to continue its growth trajectory, driven by the persistent demand for effective treatments and the expanding elderly population. Moreover, government agencies and eye health organizations have been actively involved in raising awareness about dry eye syndrome and promoting regular eye check-ups, further driving the demand for treatments. For instance, the National Eye Institute (NEI) in the United States provides extensive resources on dry eye and supports research into new treatments.

Dry Eye Syndrome Treatment Market Key Developments:

  • In 2021, the USA Food and Drug Administration (FDA) approved one of the dry eye products, Tyrvaya nasal spray. This spray simulates tear, oil, and mucin production, which eliminates burning sensations.
  • In January 2017, Novaliq announced the positive top-line results of phase 2 clinical trial evaluating CyclASol in adults with moderate to severe dry eye disease.
  • In June 2015, Allergan plc, a pharmaceutical company acquired Oculeve Inc, a medical device company that focuses on new technologies for dry eye disease to improve market position in the dry eye syndrome treatment market.
  • In July 2013, Novaliq GmbH won European approval for its lubricating, drug-delivering eye drop NovaTears, designed for over-the-counter treatment of dry eye syndrome.

Global Dry Eye Syndrome Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.5%

Largest Market

North-America

Fastest Growing Market

Asia Pacific

Dry Eye Syndrome Treatment Market Dynamics

The dry eye syndrome treatment market is primarily driven by the increasing prevalence of the condition, particularly among the aging population and those with prolonged digital device use. The World Health Organization estimates that the proportion of the world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050, significantly impacting the dry eye syndrome market. Another key driver is the growing awareness about eye health and the availability of over-the-counter treatments. The expansion of specialty eye care clinics and the integration of dry eye treatments into primary care practices are also contributing to market growth. The development of new treatment options, including biologics and gene therapies, is reshaping the market landscape. There is also a growing interest in natural and preservative-free formulations, particularly among patients with sensitive eyes or those concerned about long-term preservative use.

Global Dry Eye Syndrome Treatment Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 6,389.2 million

Market CAGR

9.5%

By Product Type

  • Cyclosporine
  • Topical Corticosteroids
  • Artificial Tears
  • Punctal Plugs
    • Removable
    • Dissolvable
  • Oral Omega Supplements
  • Others

By Dosage Form

  • Gels
  • Eye Solutions
  • Capsules & Tablets
  • Eye Drops
  • Ointments

By Prescription Mode

  • Rx
  • OTC
  • Medical Device

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Eye Health Clinics
  • Others

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

Frequently Asked Questions

The Dry Eye Syndrome Treatment Market was valued at US$ 6,389.2 million in 2023 and is expected to grow at a 9.5% CAGR from 2024 to 2030.

Nicox (France), Allergan (U.S.), Auven Therapeutics (U.S.), Novartis AG (Switzerland), AFT Pharmaceuticals (New Zealand)

Asia Pacific is the fastest-growing region for dry eye syndrome treatment market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

Key Market Players

  • Allergan plc (AbbVie Inc.)
  • Novartis AG
  • Bausch Health Companies Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Johnson & Johnson Vision
  • Otsuka Pharmaceutical Co., Ltd.
  • Lupin Ltd.
  • Akorn Operating Company LLC
  • Reckitt Benckiser Group PLC
  • OASIS Medical

Related Industry Reports